CIBC Asset Management Inc - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC Asset Management Inc ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$10,640,000
+57.0%
457,052
+7.2%
0.07%
+50.0%
Q1 2018$6,777,000
+160.0%
426,335
+242.3%
0.04%
+175.0%
Q4 2017$2,607,000
+51.1%
124,559
+3.2%
0.02%
+45.5%
Q3 2017$1,725,000
-20.6%
120,722
-3.5%
0.01%
-26.7%
Q2 2017$2,172,000
+64.3%
125,107
+4.4%
0.02%
+66.7%
Q1 2017$1,322,000
-81.2%
119,852
-75.3%
0.01%
-82.4%
Q4 2016$7,027,000
-41.6%
484,618
-1.1%
0.05%
-42.7%
Q3 2016$12,024,000
+93.4%
489,967
+57.9%
0.09%
+89.4%
Q2 2016$6,216,000
-30.2%
310,398
-8.5%
0.05%
-29.9%
Q1 2016$8,909,000
-87.2%
339,392
-50.7%
0.07%
-88.3%
Q4 2015$69,857,000
-54.3%
687,832
-19.9%
0.58%
-52.9%
Q3 2015$152,710,000
-21.2%
858,688
-1.6%
1.22%
-9.4%
Q2 2015$193,793,000
+13.2%
872,479
+0.5%
1.35%
+10.9%
Q1 2015$171,238,000
+39.0%
867,995
+1.0%
1.22%
+47.8%
Q4 2014$123,197,000
+3.4%
859,264
-5.6%
0.82%
+15.6%
Q3 2014$119,168,000
+5.9%
910,141
+2.2%
0.71%
+11.4%
Q2 2014$112,524,000
+7.8%
890,254
+12.2%
0.64%
+3.6%
Q1 2014$104,411,000
+35.2%
793,489
+20.3%
0.62%
+30.2%
Q4 2013$77,254,000
+11.7%
659,340
-0.5%
0.47%
+7.0%
Q3 2013$69,183,000
+27.2%
662,523
+5.1%
0.44%
+19.1%
Q2 2013$54,377,000630,3660.37%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2018
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders